Contacts
Get in touch
Close

Contacts

Office No. 106, 1st Floor,
Jumeirah Lake Towers, Cluster X,
Jumeirah Bay X3, Sheik Zayed Road, Dubai, UAE

+971 4 578 7232
P.O.Box: 338334

[email protected]

Slide Background

ELEVATE YOUR OPTION

For
Precision Medicine

Slide Background
PrIMe
A cancer molecular test that incorporates a 500+ tumor-related multi-gene panel associated with targeted therapies.
Slide Background
HerediGENE
A test that fully analyzes a panel of genes, including BRCA1 and BRCA2, which are responsible for increased risk of developing breast, ovarian, and other hereditary cancers.
previous arrowprevious arrow
next arrownext arrow

Sciphram Trading FZCO

High-sensitivity testing for Cancer diagnosis  and treatment planning.

At Scipharm, we are committed to revolutionizing the field of molecular medicine by providing cutting-edge tumor profiling and targeted therapy solutions. Established in 2021 in the UAE, our mission is to enhance precision medicine options with the highest quality services, empowering physicians to make informed treatment decisions.

Call us today:

capabilitiesIdentifying genetic alterations for targeted therapies

Molecular Genetics

Our labs is specialized in molecular genetics. Utilizing cutting edge technology, our company offers all the validated molecular tools for the diagnosis, prognosis and individualized treatment of cancer patients.

Oncology

It is generally accepted that cancer is a disease with a genetic background related to acquired or hereditary mutations, gene translocations and over expression of some genes. Mutations take place in genes that are responsible for the smooth operation of the organism with regards to the cellular proliferation, differentiation and cellular death. The majority of cancers is sporadic and is presented in relatively elder people, as they occur from the accumulation of mutations in genes such as K-RAS, EGFR, BRAF, P53 etc. Such mutations are also related to response to targeted therapies.

Client Satisfaction
0 K+
Hereditary Testing Diagnosis Early Stage Therapy Late Stage Therapy Early Detection Hereditary Testing Diagnosis Early Stage Therapy Late Stage Therapy Early Detection

about usComprehensive Tumor Profiling & Targeted Therapy Solutions.

At Scipharm, we are committed to revolutionizing the field of molecular medicine by providing cutting-edge tumor profiling and targeted therapy solutions. Established in 2021 in the UAE, our mission is to enhance precision medicine options with the highest quality services, empowering physicians to make informed treatment decisions.

Through our strategic partnership with Genekor, a globally recognized leader in molecular medicine quality assurance, we bring highly sensitive and specific molecular assays to clinical practice, ensuring accuracy and reliability in cancer diagnostics.

True analyses
0 %

European data

The trials of every day
0 +

European data

Science

TODAY

TOMORROW